Alaska Airlines Flies First Commercial
Flight with Gevo’s Cellulosic Alcohol-to-Jet Fuel- Gevo to
Host Conference Call Today at 4:30 p.m. EST/2:30 MST -
Gevo, Inc. (NASDAQ:GEVO) today announced financial results for the
three months ended September 30, 2016. Key highlights for the
quarter included:
- Gevo produced approximately 145,000 gallons of isobutanol
during the quarter.
- On November 14, Alaska Airline flew the first commercial flight
with Gevo’s cellulosic Alcohol-to-Jet fuel (“ATJ”). Previously, on
October 11, 2016, Gevo announced that it had completed production
of the world’s first cellulosic renewable jet fuel that is
specified for commercial flights. Gevo successfully adapted
its patented technologies to convert cellulosic sugars derived from
wood waste into renewable isobutanol, which was then further
converted into its ATJ. This ATJ meets the ASTM D7566 specification
allowing it to be used for commercial flights. Gevo produced over
1,000 gallons of the cellulosic ATJ.
- On November 10, Gevo announced that gasoline blended with its
isobutanol and marketed for use in automobiles has begun to be sold
in the Houston area. This marks the first time that Gevo’s
isobutanol has been specifically targeted towards on-road
vehicles. Musket Corporation is Gevo’s distribution partner
serving the Houston market. Musket is blending up specially
formulated gasoline containing Gevo’s isobutanol to distribute into
the on-road automobile market.
- On September 7, 2016, Gevo announced that it had entered into a
heads of agreement with Deutsche Lufthansa AG (“Lufthansa”) to
supply Gevo’s ATJ from its first commercial hydrocarbons facility,
intended to be built in Luverne, MN. The terms of the
agreement contemplate Lufthansa purchasing up to 8 million gallons
per year of ATJ or up to 40 million gallons over the 5-year life of
the off-take agreement. The heads of agreement establishes a
selling price that is expected to allow for an appropriate level of
return on the capital required to build-out Gevo’s first commercial
scale hydrocarbons facility. The heads of agreement is
non-binding and is subject to completion of a binding off-take
agreement and other definitive documentation between Gevo and
Lufthansa.
- On September 30, 2016, Gevo voluntarily paid off, in full,
all outstanding amounts owed under the Amended Agri-Energy Loan
Agreement and all material commitments and obligations under the
Loan and Security Agreement and associated documents were
terminated. In connection with the repayment, TriplePoint Capital
LLC terminated all of its security interests under the Loan and
Security Agreement (including any mortgages and membership interest
pledges). In addition, the guaranties by Gevo and Gevo Development,
LLC of the obligations under the Loan and Security Agreement were
also terminated.
- On September 13, 2016, Gevo completed the sale of 24,800,000
Series E units consisting of one share of our common stock and a
half of one Series I warrant to purchase one share of common stock
and 3,700,000 Series F units consisting of a pre-funded Series J
warrant and a half of one Series I warrant to purchase one share of
common stock, pursuant to an underwritten public offering.
Gevo received gross proceeds of approximately $15.6 million, not
including any future proceeds from the exercise of the
warrants.
- On September 7, 2016, Gevo entered into private exchange
agreements with holders of its 7.5% convertible senior notes due in
2022 but with an embedded put right on July 1, 2017 (the “2022
Notes”), to exchange an aggregate of $11.4 million of principal
amount of 2022 Notes for an aggregate of 13,999,354 shares of its
common stock. These exchanges reduced the outstanding
principal amount of the 2022 Notes to $11.0 million.
1 Adjusted Net Loss Per Share is calculated by
adding back non-cash gains and/or losses recognized in the quarter
due to the changes in the fair value of certain of our financial
instruments, such as warrants, convertible debt and embedded
derivatives; a reconciliation of Adjusted Loss Per Share to Loss
Per Share is provided in the financial statement tables following
this release.
2 Cash EBITDA loss is calculated by adding
back depreciation and non-cash stock compensation to GAAP Loss From
Operations; a reconciliation of cash EBITDA loss to GAAP loss from
operations is provided in the financial statement tables following
this release.
Outlook for 2016
As previously disclosed, Gevo restarted production
of isobutanol at its production facility in Luverne, MN, (the
“Luverne Plant”) in March 2016. All operations, including the
distillation system, are now up and running. During the third
quarter, Gevo produced approximately 145,000 gallons of
isobutanol. During 2016, Gevo has produced a total of
approximately 240,000 gallons of isobutanol.
In terms of its previously issued 2016 guidance,
Gevo expects to:
- Produce approximately 500,000 gallons of isobutanol at the
Luverne Plant for the year ending December 31, 2016, near the
low-end of the previously announced range of 500,000-650,000
gallons.
- Decrease the variable cost of producing isobutanol at the
Luverne Plant to a range of $3.00-$3.50/gallon (assumes corn price
of $3.65 per bushel and nets the value of the isobutanol
distiller's grains (the "iDGs™"), enabling isobutanol to be
produced at a positive contribution margin, based on an expected
average selling price for isobutanol of between
$3.50-$4.50/gallon.
- Increase sales of isobutanol into core markets such as the
renewable ATJ fuel, marina, off-road, isooctane and solvents
markets.
- Achieve an average quarterly corporate-wide EBITDA burn rate
(excluding stock-based compensation) of $3.5-$4.5 million.
Corporate-wide EBITDA burn rate is calculated by adding back
depreciation and non-cash stock compensation to GAAP Loss From
Operations.
Through the balance of 2016 and into 2017, we will
continue to be focused on optimization work to improve the Luverne
Plant at its current scale, but more importantly with a view
towards significantly expanding the Luverne Plant. We plan to
optimize the overall production processes with the intent of
improving robustness and consistency of production, increasing
production volumes, and potentially producing specific grades of
isobutanol tailored for specific applications. This
optimization work could result in us needing to add more equipment
(tanks, controls, pumps, distillation columns, etc.), systems or
processes in the future at the Luverne Plant.
Despite the production ramp-up delays described
above, we expect that by the end of 2016 to have the capability to
be at a production run rate equivalent to 1.5 million gallons per
year at the Luverne Plant. Although we expect to have this
production capability, we currently expect to run at a rate less
than 1.5 million gallons per year as we scale up and test new
process improvements to further reduce costs and optimize
production in general at the Luverne Plant with a view towards
significantly expanding production capacity in the
future.
“We continue to make solid progress with our
production at Luverne and with our efforts to develop markets for
our products. I am especially pleased that our isobutanol is
now being blended with gasoline and sold for use in automobiles in
the Houston area. This marks the first time that our
isobutanol has been specifically targeted towards on-road
vehicles,” said Dr. Patrick Gruber, Gevo’s Chief Executive
Officer.
“In the near term, we will continue our efforts to
increase isobutanol production and optimize operations at the
current Luverne facility with a view towards significantly
expanding isobutanol production capacity at Luverne and building
our first commercial hydrocarbon facility to process our renewable
isobutanol into renewable alcohol to jet fuel and isooctane,” added
Dr. Gruber.
Financial Highlights
Revenues for the third quarter of 2016 were $6.9
million compared with $8.0 million in the same period in 2015.
During the third quarter of 2016, revenues derived at the Luverne
plant were $6.4 million, a decrease of approximately $1.2 million
from the same period in 2015. This was primarily a result of lower
ethanol production, ethanol prices and distiller grain prices in
the 3rd quarter of 2016 versus the same period in 2015.
During the third quarter of 2016, hydrocarbon
revenues were $0.5 million, $0.3 million higher than the same
period in 2015. Gevo’s hydrocarbon revenues are comprised of sales
of jet fuel, isooctane and isooctene.
Gevo generated grant and other revenue of $0.1
million during the third quarter of 2016, down $0.1 million as
compared to the same period in 2015.
Cost of goods sold was $9.7 million for the three
months ended September 30, 2016, compared with $10.6 million in the
same quarter in 2015. Cost of goods sold included approximately
$8.1 million associated with the production of ethanol, isobutanol
and related products and approximately $1.5 million in
depreciation expense.
Gross loss was $2.7 million for the three months
ended September 30, 2016.
Research and development expense decreased by
approximately $0.4 million during the three months ended September
30, 2016, compared with the same quarter in 2015, due primarily to
a reduction in employee related expenses.
Selling, general and administrative expense
decreased by $2.9 million during the three months ended September
30, 2016, compared with the same quarter in 2015, due primarily to
a decrease of $2.5 million in general legal expenses,
including litigation related expenses.
Loss from operations in the third quarter of 2016
was $6.1 million, compared with $9.3 million in the same quarter in
2015.
Non-GAAP cash EBITDA loss in the third quarter of
2016 was $4.1 million, compared with $6.4 million in the same
quarter in 2015.
Interest expense in the third quarter of 2016 was
$2.1 million, which was flat as compared to the same quarter last
year.
During the three months ended September 30, 2016,
there was no change in the value of the embedded derivatives in the
2022 Notes, as the derivatives have had no meaningful value since
the third quarter of 2014. However, Gevo did incur a non-cash
loss of $0.9 million in the quarter as a result of exchanging an
aggregate of $11.4 million principal amount of the 2022 Notes for
shares of Gevo’s common stock in September.
During the three months ended September 30, 2016,
Gevo also incurred a non-cash loss of $1.9 million during the
quarter due to the quarterly mark-to-market valuation of the 2017
Notes.
During the three months ended September 30, 2016,
the estimated fair value of the derivative warrant liability
decreased by $1.2 million, resulting in a non-cash gain from change
in fair value of derivative warrant liability.
The net loss for the third quarter of 2016 was $9.8
million, compared with $6.5 million during the same period in
2015.
The non-GAAP adjusted net loss for the third
quarter of 2016 was $8.2 million, compared with $11.4 million
during the same period in 2015.
The cash position at September 30, 2016 was $31.1
million.
Webcast and Conference Call
Information
Hosting today’s conference call at 4:30 p.m. EST
(2:30 p.m. MST) will be Dr. Patrick Gruber, Chief Executive
Officer, Mike Willis, Chief Financial Officer, and Geoff Williams,
General Counsel. They will review Gevo’s financial results and
provide an update on recent corporate highlights.
To participate in the conference call, please dial
1(888) 771-4371 (inside the U.S.) or 1(847) 585-4405 (outside the
U.S.) and reference the access code 43605382. A replay of the call
and webcast will be available two hours after the conference call
ends on November 14, 2016. To access the replay, please dial 1(630)
652-3042 (inside the US) or 1(888) 843-7419 (outside the US) and
reference the access code 43605382. The archived webcast will be
available in the Investor Relations section of Gevo's website at
www.gevo.com.
About Gevo
Gevo is a leading renewable technology, chemical
products, and next generation biofuels company. Gevo has developed
proprietary technology that uses a combination of synthetic
biology, metabolic engineering, chemistry and chemical engineering
to focus primarily on the production of isobutanol, as well as
related products from renewable feedstocks. Gevo’s strategy is to
commercialize biobased alternatives to petroleum-based products to
allow for the optimization of fermentation facilities’ assets, with
the ultimate goal of maximizing cash flows from the operation of
those assets. Gevo produces isobutanol, ethanol and high-value
animal feed at its fermentation plant in Luverne, Minnesota. Gevo
has also developed technology to produce hydrocarbon products from
renewable alcohols. Gevo currently operates a biorefinery in
Silsbee, Texas, in collaboration with South Hampton Resources Inc.,
to produce renewable jet fuel, octane, and ingredients for plastics
like polyester. Gevo has a marquee list of partners including The
Coca-Cola Company, Toray Industries Inc. and Total SA, among
others. Gevo is committed to a sustainable bio-based economy that
meets society’s needs for plentiful food and clean air and
water.
Forward-Looking Statements
Certain statements in this press release may
constitute "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements relate to a variety of matters,
including, without limitation, statements related to the ability of
Gevo to produce isobutanol at Gevo’s Luverne, Minnesota production
facility, Gevo’s ability to achieve its production and cost
guidance, Gevo’s ability to secure new customer relationships
across core markets, and other statements that are not purely
statements of historical fact. These forward-looking
statements are made on the basis of the current beliefs,
expectations and assumptions of the management of Gevo and are
subject to significant risks and uncertainty. Investors are
cautioned not to place undue reliance on any such forward-looking
statements. All such forward-looking statements speak only as of
the date they are made, and Gevo undertakes no obligation to update
or revise these statements, whether as a result of new information,
future events or otherwise. Although Gevo believes that the
expectations reflected in these forward-looking statements are
reasonable, these statements involve many risks and uncertainties
that may cause actual results to differ materially from what may be
expressed or implied in these forward-looking statements. For a
further discussion of risks and uncertainties that could cause
actual results to differ from those expressed in these
forward-looking statements, as well as risks relating to the
business of Gevo in general, see the risk disclosures in the Annual
Report on Form 10-K of Gevo for the year ended December 31, 2015,
and in subsequent reports on Forms 10-Q and 8-K and other filings
made with the U.S. Securities and Exchange Commission by Gevo.
Non-GAAP Financial Information
This press release contains financial measures that
do not comply with U.S. generally accepted accounting principles
(GAAP), non-GAAP cash EBITDA and adjusted loss per share. On a
non-GAAP basis, non-GAAP cash EBITDA excludes non-cash items such
as depreciation and stock-based compensation. On a non-GAAP basis,
non-GAAP adjusted loss per share excludes non-cash gains and/or
losses recognized in the quarter due to the changes in the fair
value of certain of our financial instruments, such as warrants,
convertible debt and embedded derivatives. Management believes
these measures are useful to supplements to its GAAP financial
statements with this non-GAAP information because management uses
such information internally for its operating, budgeting and
financial planning purposes. These non-GAAP financial measures also
facilitate management's internal comparisons to Gevo’s historical
performance as well as comparisons to the operating results of
other companies. In addition, Gevo believes these non-GAAP
financial measures are useful to investors because they allow for
greater transparency into the indicators used by management as a
basis for its financial and operational decision making. Non-GAAP
information is not prepared under a comprehensive set of accounting
rules and therefore, should only be read in conjunction with
financial information reported under U.S. GAAP when understanding
Gevo’s operating performance. A reconciliation between GAAP and
non-GAAP financial information is provided in the financial
statement tables below.
Reverse Stock Split
On April 15, 2015, our Board of Directors approved
a reverse split of our common stock, par value $0.01, at a ratio of
one-for-fifteen. This reverse stock split became
effective on April 20, 2015 and, unless otherwise indicated, all
share amounts, per share data, share prices, exercise prices and
conversion rates set forth in this press release and the
accompanying consolidated financial statements have, where
applicable, been adjusted to reflect this reverse stock
split.
Gevo, Inc. |
Condensed Consolidated Statements of Operations
Information |
(Unaudited, in thousands, except share and per share
amounts) |
|
|
|
Three Months EndedSeptember
30, |
|
|
Nine Months EndedSeptember
30, |
|
|
|
2016 |
|
|
2015 |
|
|
2016 |
|
|
2015 |
|
Revenue and cost
of goods sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ethanol sales and related products,
net |
|
$ |
6,363 |
|
|
$ |
7,551 |
|
|
$ |
19,288 |
|
|
$ |
20,604 |
|
Hydrocarbon revenue |
|
|
451 |
|
|
|
192 |
|
|
|
1,462 |
|
|
|
1,449 |
|
Grant and other revenue |
|
|
130 |
|
|
|
274 |
|
|
|
627 |
|
|
|
787 |
|
Total revenues |
|
|
6,944 |
|
|
|
8,017 |
|
|
|
21,377 |
|
|
|
22,840 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold |
|
|
9,650 |
|
|
|
10,629 |
|
|
|
28,862 |
|
|
|
29,761 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross loss |
|
|
(2,706 |
) |
|
|
(2,612 |
) |
|
|
(7,485 |
) |
|
|
(6,921 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
expense |
|
|
1,156 |
|
|
|
1,527 |
|
|
|
3,670 |
|
|
|
5,014 |
|
Selling, general and administrative
expense |
|
|
2,273 |
|
|
|
5,135 |
|
|
|
6,337 |
|
|
|
13,406 |
|
Total operating
expenses |
|
|
3,429 |
|
|
|
6,662 |
|
|
|
10,007 |
|
|
|
18,420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
(6,135 |
) |
|
|
(9,274 |
) |
|
|
(17,492 |
) |
|
|
(25,341 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (expense)
income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(2,100 |
) |
|
|
(2,121 |
) |
|
|
(6,497 |
) |
|
|
(6,186 |
) |
(Loss)/Gain on exchange or
conversion of debt |
|
|
(920 |
) |
|
|
- |
|
|
|
(920 |
) |
|
|
285 |
|
(Loss)/Gain on extinguishment of
warrant liability |
|
|
5 |
|
|
|
- |
|
|
|
(918 |
) |
|
|
1,775 |
|
(Loss)/Gain from change in fair
value of the 2017 Notes |
|
|
(1,854 |
) |
|
|
157 |
|
|
|
(3,629 |
) |
|
|
3,582 |
|
(Loss)/Gain from change in fair
value of derivative warrant liability |
|
|
1,154 |
|
|
|
4,719 |
|
|
|
(4,171 |
) |
|
|
(2,361 |
) |
Loss on issuance of equity |
|
|
- |
|
|
|
- |
|
|
|
(1,519 |
) |
|
|
- |
|
Other income |
|
|
1 |
|
|
|
- |
|
|
|
207 |
|
|
|
14 |
|
Total other expense, net |
|
|
(3,714 |
) |
|
|
2,755 |
|
|
|
(17,447 |
) |
|
|
(2,891 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(9,849 |
) |
|
$ |
(6,519 |
) |
|
$ |
(34,939 |
) |
|
$ |
(28,232 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share - basic
and diluted |
|
$ |
(0.10 |
) |
|
$ |
(0.39 |
) |
|
$ |
(0.62 |
) |
|
$ |
(2.22 |
) |
Net loss per share - basic
and diluted |
|
|
96,753,965 |
|
|
|
16,688,632 |
|
|
|
56,285,311 |
|
|
|
12,700,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gevo, Inc. |
Condensed Consolidated Balance Sheet
Information |
(Unaudited, in thousands) |
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2016 |
|
|
2015 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
31,063 |
|
|
$ |
17,031 |
|
Accounts receivable |
|
|
1,079 |
|
|
|
1,391 |
|
Inventories |
|
|
3,203 |
|
|
|
3,487 |
|
Prepaid expenses and other current
assets |
|
|
844 |
|
|
|
731 |
|
Total current assets |
|
|
36,189 |
|
|
|
22,640 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment,
net |
|
|
76,507 |
|
|
|
76,777 |
|
Deposits and other assets |
|
|
3,414 |
|
|
|
3,414 |
|
Total assets |
|
$ |
116,110 |
|
|
$ |
102,831 |
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable, accrued
liabilities and other current liabilities |
|
$ |
4,404 |
|
|
$ |
7,476 |
|
Derivative warrant liability |
|
|
10,723 |
|
|
|
10,493 |
|
Current portion of secured debt,
net |
|
|
- |
|
|
|
330 |
|
Current portion 2017 Notes recorded
at fair value |
|
|
25,194 |
|
|
|
- |
|
Total current liabilities |
|
|
40,321 |
|
|
|
18,299 |
|
Long-term portion of
secured debt, net |
|
|
- |
|
|
|
153 |
|
Long term portion 2017 Notes
recorded at fair value |
|
|
- |
|
|
|
21,565 |
|
2022 Notes, net |
|
|
8,779 |
|
|
|
14,341 |
|
Other long-term liabilities |
|
|
18 |
|
|
|
147 |
|
Total liabilities |
|
|
49,118 |
|
|
|
54,505 |
|
|
|
|
|
|
|
|
|
|
Total
stockholders’
equity |
|
|
66,992 |
|
|
|
48,326 |
|
Total liabilities and stockholders'
equity |
|
$ |
116,110 |
|
|
$ |
102,831 |
|
|
|
|
|
|
|
|
|
|
Gevo,
Inc. |
Condensed Consolidated Cash Flow Information |
(Unaudited, in thousands) |
|
|
|
Nine Months Ended September 30, |
|
|
|
2016 |
|
|
2015 |
|
Operating
Activities |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(34,939 |
) |
|
$ |
(28,232 |
) |
Adjustments to reconcile
net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Loss/(Gain) from change in fair
value of derivative warrant liability |
|
|
4,171 |
|
|
|
2,361 |
|
Loss/(Gain) from change in fair
value of the 2017 Notes |
|
|
3,629 |
|
|
|
(3,582 |
) |
Loss/(Gain) on exchange or
conversion of debt |
|
|
920 |
|
|
|
(285 |
) |
Gain on extinguishment of warrant
liability |
|
|
918 |
|
|
|
(1,775 |
) |
Loss on equity issuance |
|
|
1,519 |
|
|
|
- |
|
Stock-based compensation |
|
|
812 |
|
|
|
1,953 |
|
Depreciation and amortization |
|
|
5,038 |
|
|
|
4,897 |
|
Non-cash interest expense |
|
|
3,339 |
|
|
|
2,740 |
|
Changes in operating
assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
312 |
|
|
|
1,227 |
|
Inventories |
|
|
284 |
|
|
|
1,589 |
|
Prepaid expenses and other current
assets |
|
|
(113 |
) |
|
|
114 |
|
Accounts payable, accrued expenses,
and long-term liabilities |
|
|
(2,095 |
) |
|
|
(2,019 |
) |
Net cash used in operating
activities |
|
|
(16,205 |
) |
|
|
(21,012 |
) |
|
|
|
|
|
|
|
|
|
Investing
Activities |
|
|
|
|
|
|
|
|
Acquisitions of property,
plant and equipment |
|
|
(5,520 |
) |
|
|
(271 |
) |
Proceeds from sales tax
refund for property, plant and equipment |
|
|
- |
|
|
|
144 |
|
Net cash used in investing
activities |
|
|
(5,520 |
) |
|
|
(127 |
) |
|
|
|
|
|
|
|
|
|
Financing
Activities |
|
|
|
|
|
|
|
|
Payments on secured debt |
|
|
(504 |
) |
|
|
(236 |
) |
Debt and equity offering costs |
|
|
(3,295 |
) |
|
|
(2,785 |
) |
Proceeds from issuance of common
stock upon exercise of stock options and employee stock
purchase plan |
|
|
- |
|
|
|
3 |
|
Proceeds from issuance of common
stock and common stock units |
|
|
28,661 |
|
|
|
23,850 |
|
Proceeds from the exercise of
warrants |
|
|
10,895 |
|
|
|
10,151 |
|
Net cash provided by financing
activities |
|
|
35,757 |
|
|
|
30,983 |
|
|
|
|
|
|
|
|
|
|
Net increase in cash and
cash equivalents |
|
|
14,032 |
|
|
|
9,844 |
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents |
|
|
|
|
|
|
|
|
Beginning of period |
|
|
17,031 |
|
|
|
6,359 |
|
End of period |
|
$ |
31,063 |
|
|
$ |
16,203 |
|
|
|
|
|
|
|
|
|
|
Gevo,
Inc. |
Reconciliation of GAAP to Non-GAAP Financial
Information |
(Unaudited, in thousands) |
|
|
|
Three Months EndedSeptember
30, |
|
|
Nine Months EndedSeptember
30, |
|
Non-GAAP Cash
EBITDA: |
|
2016 |
|
|
2015 |
|
|
2016 |
|
|
2015 |
|
Gevo Development, LLC /
Agri-Energy, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
$ |
(3,403 |
) |
|
$ |
(3,165 |
) |
|
$ |
(9,896 |
) |
|
$ |
(9,568 |
) |
Depreciation and amortization |
|
|
1,503 |
|
|
|
1,420 |
|
|
|
4,450 |
|
|
|
4,288 |
|
Non-cash stock-based
compensation |
|
|
5 |
|
|
|
31 |
|
|
|
10 |
|
|
|
29 |
|
Non-GAAP cash EBITDA |
|
$ |
(1,895 |
) |
|
$ |
(1,714 |
) |
|
$ |
(5,436 |
) |
|
$ |
(5,251 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gevo, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
$ |
(2,732 |
) |
|
$ |
(6,109 |
) |
|
$ |
(7,596 |
) |
|
$ |
(15,773 |
) |
Depreciation and amortization |
|
|
255 |
|
|
|
196 |
|
|
|
588 |
|
|
|
609 |
|
Non-cash stock-based
compensation |
|
|
265 |
|
|
|
1,229 |
|
|
|
802 |
|
|
|
1,924 |
|
Non-GAAP cash EBITDA |
|
$ |
(2,212 |
) |
|
$ |
(4,684 |
) |
|
$ |
(6,206 |
) |
|
$ |
(13,240 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gevo Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
$ |
(6,135 |
) |
|
$ |
(9,274 |
) |
|
$ |
(17,492 |
) |
|
$ |
(25,341 |
) |
Depreciation and amortization |
|
|
1,758 |
|
|
|
1,616 |
|
|
|
5,038 |
|
|
|
4,897 |
|
Non-cash stock-based
compensation |
|
|
270 |
|
|
|
1,260 |
|
|
|
812 |
|
|
|
1,953 |
|
Non-GAAP cash EBITDA |
|
$ |
(4,107 |
) |
|
$ |
(6,398 |
) |
|
$ |
(11,642 |
) |
|
$ |
(18,491 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Adjusted
Net Loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gevo Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss |
|
|
(9,849 |
) |
|
|
(6,519 |
) |
|
|
(34,939 |
) |
|
|
(28,232 |
) |
(Loss)/Gain on exchange or
conversion of debt |
|
|
(920 |
) |
|
|
- |
|
|
|
(920 |
) |
|
|
285 |
|
(Loss)/Gain on extinguishment of
warrant liability |
|
|
5 |
|
|
|
- |
|
|
|
(918 |
) |
|
|
1,775 |
|
(Loss)/Gain from change in fair
value of the 2017 Notes |
|
|
(1,854 |
) |
|
|
157 |
|
|
|
(3,629 |
) |
|
|
3,582 |
|
(Loss)/Gain from change in fair
value of derivative warrant liability |
|
|
1,154 |
|
|
|
4,719 |
|
|
|
(4,171 |
) |
|
|
(2,361 |
) |
Loss on issuance of equity |
|
|
- |
|
|
|
- |
|
|
|
(1,519 |
) |
|
|
- |
|
Non-GAAP Net Loss |
|
$ |
(8,234 |
) |
|
$ |
(11,395 |
) |
|
$ |
(23,782 |
) |
|
$ |
(31,513 |
) |
Weighted-average number of
common shares outstanding - basic and diluted |
|
|
96,753,965 |
|
|
|
16,688,632 |
|
|
|
56,285,311 |
|
|
|
12,700,844 |
|
Non-GAAP Adjusted Net loss
per share - basic and diluted |
|
$ |
(0.09 |
) |
|
$ |
(0.68 |
) |
|
$ |
(0.42 |
) |
|
$ |
(2.48 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Contact
David Rodewald
The David James Agency, LLC
+1 805-494-9508
gevo@davidjamesagency.com
Investor Contact
Shawn M. Severson
EnergyTech Investor, LLC
+1 415-233-7094
gevo@energytechinvestor.com
@ShawnEnergyTech
www.energytechinvestor.com
Gevo (NASDAQ:GEVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gevo (NASDAQ:GEVO)
Historical Stock Chart
From Jul 2023 to Jul 2024